M Ventures (Merck)

Cambridge, Massachusetts

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Founded:2009

Firm Location:Cambridge, Massachusetts • London • Amsterdam, Netherlands • Israel • Germany • Barcelona, Spain • Netherlands • Switzerland • Bonn, Germany

M Ventures (Merck) Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Bauke Anninga M Ventures (Merck)Principal	n/a	$1.5M ($100K - $5.0M)	Investors in London, Investors in Netherlands	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists) +2
Tobias Egle M Ventures (Merck)Analyst	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in Material Science (Seed), Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Material Science (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in Impact (Seed), Investors in Material Science (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Impact (Series A), Investors in Material Science (Series A), Investors in Boston / New England (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed) +17
Daniel Franke M Ventures (Merck)Principal	n/a	$1.5M ($100K - $5.0M)	Investors in Cambridge (MA)	Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Semiconductors (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Health IT (Series A), Investors in Impact (Series A), Investors in Health & Hospital Services (Series A), Investors in Semiconductors (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Health IT (Series B), Investors in Impact (Series B), Investors in Semiconductors (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +46
Hakan Goker M Ventures (Merck)Managing Director	n/a	$1.5M ($100K - $5.0M)	Investors in Amsterdam (Netherlands)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +14
Nadiya Ishnazarova M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in London	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +21
Therese Liechtenstein M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in Switzerland	Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed) +4
Owen Lozman M Ventures (Merck)Managing Director	n/a	$1.5M ($100K - $5.0M)	Investors in London, Investors in Amsterdam (Netherlands)	Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Seed), Investors in Semiconductors (Series A), Investors in London (Other Lists) +1
Sarah Luppino M Ventures (Merck)Associate	n/a	$1.5M ($100K - $5.0M)	Investors in Barcelona (Spain)	Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed) +9
Jonathan Nash M Ventures (Merck)Associate	n/a	$1.5M ($100K - $5.0M)	Investors in London	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in London (Other Lists) +2
Christian Patze M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +24
Radhika Ramachandran M Ventures (Merck)Associate	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Semiconductors (Series B), Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +24
Sebastian Schöfer M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in Bonn (Germany)	Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Impact (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Semiconductors (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +24
Anique ter Braake M Ventures (Merck)Associate	n/a	$1.5M ($100K - $5.0M)	Investors in Netherlands	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Christian Uhrich M Ventures (Merck)Principal	n/a	$1.5M ($100K - $5.0M)	Investors in Germany	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A)
Noga Yerushalmi M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in Israel	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B) +2
Cheryl Zimberlin M Ventures (Merck)Investor	n/a	$1.5M ($100K - $5.0M)	Investors in Amsterdam (Netherlands)	Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +8